Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2025 Nov 6.
doi: 10.1007/s11255-025-04899-z. Online ahead of print.

Mineralocorticoid receptor antagonists and renal immune aging: a perspective on current evidence

Rana Muhammad Omar Draz Khan  1 , Kabeer Ali Bara  2 , Abdul Raheem Khan  2 , Ali Hassan Khan  2
Affiliations
Comment

Mineralocorticoid receptor antagonists and renal immune aging: a perspective on current evidence

Rana Muhammad Omar Draz Khan et al. Int Urol Nephrol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests.

Comment on

References

    1. Wang QR, Yang Y (2025) Mineralocorticoid receptor antagonists promote renal immunosenescence. Int Urol Nephrol 57:3299–3306 - DOI - PubMed - PMC
    1. Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P et al (2021) Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med 385:2252–2263 - DOI - PubMed
    1. Barrera-Chimal J, Jaisser F (2019) Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis. Kidney Int 96:302–319 - DOI - PubMed
    1. Nikolich-Žugich J (2018) The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol 19:10–19 - DOI - PubMed
    1. Agarwal R, Kolkhof P, Bakris G, Bauersachs J, Haller H, Wada T et al (2021) Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine. Eur Heart J 42:152–161 - DOI - PubMed

LinkOut - more resources